Arch Venture Partners' investment considerations for CBRNE products and opportunities

K. Crandell; S. Lazarus; P. J. Gardner

doi:10.1117/12.783466

1 May 2008 Arch Venture Partners' investment considerations for CBRNE products and opportunities

K. Crandell, S. Lazarus, P. J. Gardner

Proceedings Volume 6954, Chemical, Biological, Radiological, Nuclear, and Explosives (CBRNE) Sensing IX; 69540U (2008) https://doi.org/10.1117/12.783466
Event: SPIE Defense and Security Symposium, 2008, Orlando, Florida, United States

Abstract

ARCH is interested in building leading, highly-valued companies from leading research. Toward that end we value innovations created by the leading researchers in the world, many of which are funded to solve critical scientific challenges including those in the instrumentation and CBRNE area. The most important CBRNE innovations we have seen at ARCH are breakthroughs involving significant unaddressed technology risk and have the potential for broad proprietary intellectual property as a result. The model ARCH has evolved in instrumentation is to look for a breakthrough innovation, with strong intellectual property and continue to strengthen the patent estate through the life of the company. ARCH looks to build companies around leading interdisciplinary scientific and engineering teams, and we favor platform technology that can be applied to multiple market applications both commercial and government. As part of a strategy to build a great company, addressing important CBRNE challenges can help a company strengthen its technical team and its IP estate. This supports a focus on early low volume markets on the way toward addressing a fuller portfolio of applications. Experienced Venture Capitalists can help this process by identifying important executive talent, partners and applications, offering financial syndication strength, and helping shape the company's strategy to maximize the ultimate value realized.

Citation Download Citation

K. Crandell, S. Lazarus, and P. J. Gardner "Arch Venture Partners' investment considerations for CBRNE products and opportunities", Proc. SPIE 6954, Chemical, Biological, Radiological, Nuclear, and Explosives (CBRNE) Sensing IX, 69540U (1 May 2008); https://doi.org/10.1117/12.783466

ACCESS THE FULL ARTICLE

INSTITUTIONAL
Select your institution to access the SPIE Digital Library.

SELECT YOUR INSTITUTION

PERSONAL
Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.

PERSONAL SIGN IN

No SPIE Account? Create one

PURCHASE THIS CONTENT

SUBSCRIBE TO DIGITAL LIBRARY

50 downloads per 1-year subscription

Members: $195

Non-members: $335 ADD TO CART

25 downloads per 1 - year subscription

Members: $145

Non-members: $250 ADD TO CART

PURCHASE SINGLE ARTICLE

Includes PDF, HTML & Video, when available

Members: $17.00

Non-members: $21.00 ADD TO CART

PROCEEDINGS
4 PAGES

DOWNLOAD PAPER SAVE TO MY LIBRARY

GET CITATION

RIGHTS & PERMISSIONS

Get copyright permission Get copyright permission on Copyright Marketplace

KEYWORDS

Weapons of mass destruction

Intellectual property

Standards development

Chemical elements

Instrument modeling

Patents

Software development

Show All Keywords

Keywords/Phrases

Search In:

Publication Years